ZE

Zepp Health Corporation

ZEPPTechnologyNASDAQ

Consumer Electronics · Last scanned Oct 24, 2026

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$258.9M
+41.8% YoY
Net Income
-$40.1M
+47.1% YoY
EBITDA
-$25.2M
+46.7% YoY

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Oct 20CONFIRMED▲ RSI OversoldRSI 10.9, below 30, stock may be oversold
Oct 19CONFIRMED▲ RSI OversoldRSI 16.5, below 30, stock may be oversold
About Zepp Health Corporation

Headquartered within the technology sector, Zepp Health Corporation focuses on Consumer Electronics services and products. Zepp Health Corporation operates as a smart wearable and health technology company worldwide. Valued at $38.3M, ZEPP is a micro-cap name in its sector. It empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura.

Where ZEPP stands vs its 150-day and 200-day moving averages

As of the October 20, 2026 close, ZEPP finished 61.98% below its 150-day moving average ($7.68) and 74.11% below its 200-day moving average ($11.28). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.

Is ZEPP overbought or oversold?

At the October 20, 2026 close, ZEPP's RSI(14) was 10.9, in oversold territory (below 30). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.

Key stats
Market Cap$38.3M
Fwd P/E-65.25
EPS$-6.08
Beta1.81
52W Change-93.7%
Dividend Yield0.00%
ROE-21.2%
Analysis

Zepp Health Corporation carries $134.3M in total debt against $69.7M in cash reserves — debt is roughly 1.9x the cash position. Managing this leverage effectively will be important for long-term financial stability. ROE of -21.2% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $613.6M (2022) to $258.9M (2025), a 58% decline worth watching.

A beta of 1.81 means ZEPP is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Zepp Health Corporation's trajectory.

Links
More Technology stocks
Browse all stocks →
⚠Not financial advice. Scanance shows end-of-day technical indicators (not real-time prices) for information only. Results can be wrong; past performance does not guarantee future results.PrivacyTerms